Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131344) titled 'An Observational Study on the Early Pharmacodynamic Effects of Zamerovimab and Mazorelvimab injection for Rabies Post-Exposure Prophylaxis' on Sept. 1.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Guangzhou Eighth Peoples Hospital Guangzhou Medical University
Condition:
Rabies
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-01
Target Sample Size: Zemelovemazorivir monoclonal antibody observation group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=333583
Disclaimer: Curated by HT Syn...